Newsroom
Zhifei Attends 2023 World Lung Health Conference and Visits World Heal...
Zhifei Attends 2023 World Lung Health Conference and Visits World Health Organization
2023-12-27
From November 15th to 18th, the Union World Conference on Lung Health, the most prestigious academic conference in the field of global tuber...
see details 》
Zhifei and GSK reached strategic cooperation, adding a new blockbuster...
Zhifei and GSK reached strategic cooperation, adding a new blockbuster product
2023-10-12
On October 8, 2023, Chongqing Zhifei Biological Products Co., Ltd. (hereinafter referred to as "Zhifei") and GlaxoSmithKline (GSK Biologica...
Zhifei Longcom Recombinant COVID-19 Vaccine Receives Marketing Approva...
Zhifei Longcom Recombinant COVID-19 Vaccine Receives Marketing Approval in Kenya
2022-12-23
On December 22, the Company's Recombinant COVID-19 Vaccine (CHO Cell) was approved for marketing by the Pharmacy and Poisons Board (PPB) of...
Six Months Efficacy and Safety Results of Zifivax® Published in New England Journal of Medicine2022-05-05
On May 4, 2022, the team of Dr. George Fu Gao, Academician from Institute of Microbiology, Chinese Academy of Sciences (IMCAS) officially pu...
Zhifei Lvzhu and Intravacc Reach Collaboration on Developing a Novel Pertussis Vaccine2022-04-30
Beijing, China, April 29, 2022 - Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd. (“Zhifei Lvzhu”), a wholly owned subsidiary of...
Recombinant COVID-19 Vaccine (CHO Cell) Included in List of COVID-19 Vaccines for Exportation2022-04-21
Recently, Ministry of Commerce, Ministry of Industry and Information Technology, National Health Commission and the National Medical Product...
China’s First Recombinant Protein Subunit COVID-19 Vaccine Received Conditional Marketing Approval2022-04-20
On March 1, 2022, the Recombinant COVID-19 Vaccine (CHO Cell) developed by Zhifei Longcom has received Conditional Marketing Authorization (...
Recombinant COVID-19 Vaccine (CHO Cell) (Zifivax) Approved for Emergency Use in Colombia2022-04-20
On January 22, 2022, Anhui Zhifei Longcom Biopharmaceutical Co., Ltd. (Zhifei Longcom), the wholly-owned subsidiary of Chongqing Zhifei Bio...